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Abstract
The external auditory canal (EAC) is an osseocartilaginous structure extending from the auricle to the eardrum, which can be
affected by congenital, inflammatory, and neoplastic diseases, thus reconstructive materials are needed. Current biomaterial-
based approaches for the surgical reconstruction of EAC posterior wall still suffer from resorption (biological) and extrusion
(synthetic). In this study, 3D fiber deposited scaffolds based on poly(ethylene oxide terephthalate)/poly(butylene
terephthalate) were designed and fabricated to replace the EAC wall. Fiber diameter and scaffold porosity were optimized,
leading to 200 ± 33 µm and 55% ± 5%, respectively. The mechanical properties were evaluated, resulting in a Young’s
modulus of 25.1 ± 7.0 MPa. Finally, the EAC scaffolds were tested in vitro with osteo-differentiated human mesenchymal
stromal cells (hMSCs) with different seeding methods to produce homogeneously colonized replacements of interest for
otologic surgery. This study demonstrated the fabrication feasibility of EAC wall scaffolds aimed to match several important
requirements for biomaterial application to the ear under the Tissue Engineering paradigm, including shape, porosity, surface
area, mechanical properties and favorable in vitro interaction with osteoinduced hMSCs.
Graphical Abstract
This study demonstrated the fabrication feasibility of outer ear canal wall scaffolds via additive manufacturing. Aimed to
match several important requirements for biomaterial application to ear replacements under the Tissue Engineering
paradigm, including shape, porosity and pore size, surface area, mechanical properties and favorable in vitro interaction with
osteo-differentiated mesenchymal stromal cells.
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1 Introduction
The external auditory canal (EAC), also known as meatus
acusticus externus or external acoustic meatus, is an S-
shaped osseo-cartilaginous structure that extends from the
auricle to the tympanic membrane being about 4 cm in
length if measured from the tragus. The lateral one-third of
this structure is cartilaginous while the medial two-third is
bony tissue [1]. The main function of the EAC is to conduct
sound waves in the form of vibrations collected by the
auricle up to the eardrum.
Different types of lesions affecting the EAC can be
clinically diagnosed: congenital (atresia), inflammatory
(malignant otitis externa and osteomyelitis), and neoplastic
(bone tumors). Moreover, trauma and miscellaneous con-
ditions, such as squamous epithelium growth, known as
cholesteatoma, also affect the EAC [2]. The conventional
techniques for surgical treatment of chronic inflammatory
processes in the middle ear are the closed, namely, intact
canal wall up (CWU), and open, namely, canal wall down
(CWD) tympanoplasty [3]. The benefits and pitfalls of
CWU, CWD and CWD with mastoid obliteration and canal
wall reconstruction techniques are widely described in lit-
erature [3, 4]. However, the choice of technique depends on
specific factors related to the surgeon expertise, patient
typology and disease process [4]. Techniques including
reconstruction of EAC wall involve partial or complete
removal of the posterior bone wall of the meatus and the
reconstruction of this structure after elimination of a
pathological process.
Different reconstructive methods of the posterior wall of
the EAC and its removal have been reported in a dis-
tinguished review article [3]. The first studies performed in
the late fifties described the reconstruction procedure by
using autologous iliac crest bone and homograft septal
cartilage. Thereafter, many types of biologic tissue grafts
have been proposed, such as tympanic canal homograft,
muscle-periosteum-bone flap, banked femoral head frag-
ments, and autologous mastoid bone powder [3]. In 1979,
Wullstein and coworkers pioneered the implant of synthetic
biomaterials for the reconstruction of the posterior bone
wall, which paved the way to the use of polymers (Pro-
plast®, Plastipore™), ceramics and glass ceramics (Cer-
avital®, hydroxylapatite, Corail® and ionomers), as well as
metals (titanium) [5]. However, beside great efforts in
otologic surgery, the current biomaterial-based approaches
still suffer from either resorption using biological materials
or extrusion using synthetic materials, thus highlighting the
unmet need for a reliable substitute in this body setting [6].
The dismal fate of biomaterials in the ear seems to be a
consequence of the permanently inflamed and contaminated
environment, subject to vibratory movement in the case of
neighboring eardrum and ossicles, even exacerbated by the
changes in ventilation systems induced by surgery [7]. A
recently proposed approach relies on the application of
tissue engineering (TE) strategies in otology, and proof of
concept approaches have been proposed for the ossicular
chain and tympanic membrane reconstruction by in vitro
culturing scaffolds provided with a specific shape with
human mesenchymal stem cells (hMSCs) [8–11]. These
studies turned out into very good results in terms of viability
and extracellular matrix (ECM) deposition by differentiated
cells. Differently from other TE applications, otologic TE
must take into great account the specific shape and size of
the different tissues present in the outer and middle ear,
since they are key enabling factors for sound conducting
process through a precise anatomy reconstruction.
Among the conventional additive manufacturing techni-
ques, Fused Deposition Modeling (FDM) is one of the
commonly used for the production of scaffolds for hard
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tissue replacement due to the possibility to produce these
types of structures with customized mechanical properties
[12, 13]. Moreover, it is possible to produce custom-made
scaffolds with specific shapes and accurate size from
computer-aided design (CAD) models obtained from the
patients by magnetic resonance imaging or computer
tomography techniques. Three-dimensional (3D) fiber
deposition (3DF) is a type of FDM technique that has been
extensively studied for the production of scaffolds for
diverse TE applications, including bone, cartilage, osteo-
chondral defects, and trachea [14–18].
To provide a TE solution for EAC surgery, in this study
3DF scaffolds based on poly(ethylene oxide terephthalate)/
poly(butylene terephthalate) (PEOT/PBT) copolymer were
designed and fabricated to replace the EAC wall. Fiber size
and scaffold porosity were optimized to obtain a suitable
scaffold for this application, and its mechanical properties
were evaluated. Finally, the EAC scaffolds were tested
in vitro with osteoinduced hMSCs by using different
seeding methods to achieve homogeneously colonized
replacements of interest for otologic surgery. This work
aims at proposing third generation biomaterials approach,
namely, the use of scaffolds to replace EAC wall, thus
opening the way for a TE scenario to this and other otologic
applications.
2 Materials and methods
2.1 Materials
PEOT/PBT was provided by PolyVation BV (Groningen,
The Netherlands). The commercial designation of this ran-
dom block copolymer follows an aPEOTbPBTc nomen-
clature, where “a” is the molecular weight (Mw, g mol−1) of
the poly(ethylene oxide) (PEO), “b” and “c” represent the
weight ratios of PEOT and PBT, respectively. The block
copolymer used in this study was 300PEOT55PBT45. Low-
glucose (1000 mg L−1), Minimum Essential Medium Eagle
—Alpha Modification (Alpha MEM), L-glutamine,
penicillin-streptomycin (Pen-Strep), fungizone, trypsin,
phosphate buffered saline (PBS), gelatin (Type B, 75
Bloom, from bovine skin), β-glycerophosphate, ascorbic
acid, dexamethasone, Triton-X-100, neutral red, trypan
blue, Mayer’s hematoxylin solution, Eosin B, DPX
mounting medium, absolute silver nitrate, pyrogallol,
sodium thiosulfate, nuclear fast red, aluminum sulfate,
ethanol, xylene, and methanol were provided by Sigma-
Aldrich (Milan, Italy). Heat-inactivated fetal bovine serum
(FBS), AlamarBlue® and paraffin histoplast LP from
Thermo Fisher Scientific (Waltham, MA, USA). Lympho-
prep was supplied by Axis-Shield, Norway. Calcium
chloride for human use was purchased from Bioindustria
Farmaceutici (Rome, Italy). EAC wall prosthesis TPL
07.39, was kindly supplied by Audiotechnologies (Gosso-
lengo, PC, Italy). All the products were used as received, if
not otherwise specified in the methods section.
2.2 Scaffold design
The outer shape of EAC wall was designed according to a
commercially available bulk prosthesis made of hydro-
xylapatite (TPL 07.39) and in accordance with surgeons’
advices. The 3D modeling of the EAC was performed by
implementing the following steps: (1) accurate measure of
the features and geometry of commercial samples using a
digital caliper and micrometer (Mitutoyo Corp., Tokyo,
Japan) and reference structures (planar ruler, precision set
square), and (2) generation with SolidWorks software
(Dassault Systemes, France) of a 3D CAD model. For the
generation of the 3D model, a portion of hollow ellipsoid
matching the overall size of the sample was generated and
further steps were performed: (2.1) deformation of the pri-
mitive to match the geometry of the sample; (2.2) 3D cut-
ting of concave features as in the sample, and (2.3) filleting
of edges with appropriate curvature radii. Two cycles of
iteration of the above mentioned steps were performed to
verify the congruence of the 3D model and the physic
sample.
2.3 Scaffold manufacturing
A first prototype of the EAC wall was manufactured in bulk
polymer (Delrin®) with a computer numerically controlled
machine (CnC 4 Axis, Esanastri, Calcinaia, Pisa, Italy)
equipped with dremel (1050 FME, KRESS-elektrik GmbH
& Co. KG, Bisingen, Germany).
The fabrication of the porous EAC scaffold was per-
formed via 3DF deposition technique using 3D-Bio-
plotter™ (EnvisionTEC GmbH, Germany). The functioning
principle of this equipment is FDM assisted by nitrogen
(N2) gas pressure to promote the extrusion of a molten
polymer. The parameters that specifically influence the
production of the 3D scaffolds are: temperature, N2 pres-
sure, deposition velocity and extrusion nozzle diameter. A
detailed description of the system has been reported by
Moroni et al. [15, 19]. Briefly, the system is composed of a
stainless steel syringe were the PEOT/PBT was loaded and
heated at a temperature of 205 °C. After obtaining the
complete polymer melting, N2 pressure was applied at 5 bar,
while an electrovalve controlled the extrusion of the poly-
mer. For the fabrication of the EAC wall scaffold, two
nozzles with different internal diameters (I.D.) were used,
namely, G25 (I.D.= 250 µm) and G27 (I.D.= 200 µm).
The deposition velocity was optimized and varied from 56
to 196 mmmin−1. The 3D models of the EAC wall scaffold
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were uploaded into the equipment using PrimCAM soft-
ware (Primus Data, Switzerland) and the deposition patterns
were calculated. The fiber diameter (d1) obtained varied
according to the nozzle diameter used. The fiber spacing
(d2), defined as the distance between successive fibers in the
same layer, ranged in 300–600 µm and the layer thickness
(d3) ranged between 150 and 175 µm. The scaffold was built
layer upon layer with a 0–90° architecture, and the fibers
were deposited with a 90° step between successive layers.
The design and manufacturing parameters for the produced
scaffold are resumed in Table 1.
Plasma treatment is a technique that allows the
improvement of cell adhesion by changing surface rough-
ness [20]. All the produced scaffolds were treated with
Argon (Ar) plasma. Scaffolds were placed inside the radio-
frequency glow-discharge chamber (Harrick Scientific
Corp., NY, USA). A pre-vacuum was applied until a
0.01 mbar pressure was reached; a subsequent flush with Ar
gas was applied for four times. The treatment was per-
formed for 30 min at a controlled vacuum ranging in
0.1–0.2 mbar with high settings applied to the radio-
frequency coil (740 V DC, 40 mA DC, 29.6W).
2.4 Scaffold characterization
2.4.1 Scaffold morphology and porosity
Scaffold architecture and fiber morphology were analyzed
via scanning electron microscopy (SEM; Phillips XL30
ESEM-FEG). The samples were sputter-coated with gold
(Cressington, Watford, England) for 60 s prior to SEM
analysis. SEM micrographs were acquired from the top and
cross-section of the scaffolds at different magnifications.
The d1, d2, and d3 values were measured (n= 20) with
ImageJ software on SEM images from the top-view and
cross section of the produced scaffolds. Gravimetric por-
osity EAC scaffold was assessed via liquid pycnometry (n
= 3), according to the following equation:
Porosity ¼ 1M
V
 1
ρ
 
 100%; ð1Þ
where M and V are the mass (as weighted) and volume (as
from the 3D CAD model) of the scaffolds and ρ is the
density of the copolymer (300PEOT55PBT45), which
equals to 1.2 g cm−3.
The best EAC scaffold type, selected according to the
analyses listed above (i.e., G27 type), underwent an
extended characterization, including X-ray micro computed
tomography (micro-CT) scan and compressive mechanical
tests. Volumetric porosity and other dimensional features,
such as connectivity, surface/volume, and local thickness
[21, 22] of the EAC scaffold were obtained via X-ray
micro-CT, using XALT scanner (namely, “X-ray AnimaL
Tomograph” built at the CNR of Pisa) [23] with the fol-
lowing scan settings: 50 kVp, 2.5 mm Al, 0.5 mA, 640
projections over 360°, 1.1 s/projection and a spatial reso-
lution of 18.4 µm. Volumetric images were reconstructed
using a modified cone-beam filtered-back projection algo-
rithm on a matrix of 850 × 850 × 1000 voxels, with isotropic
voxel size of 25.3 µm. Images were then segmented and
quantitatively analyzed with the BoneJ plugin of the ImageJ
software [24, 25]. Using the trabecular analysis package of
BoneJ and treating the scaffold fibers as trabeculae, the
following morphological parameters of the EAC scaffold
were analyzed: total volume (TV), volume fraction occu-
pied by the material (BV/TV), surface/volume ratio (BS/
BV), local thickness (Tb.Th), connectivity and connectivity
density (Conn and Conn.D).
2.4.2 Mechanical properties of the scaffold
Compression tests were performed on cylindrical specimens
with the highest porosity pattern G27 (n= 3). 3D fiber
deposited samples in the form of cylinders were fabricated
with the following dimensions to avoid significant effects
deriving from friction forces [26]: 12.55 mm diameter (D) ×
25 mm length (L), which lead to L/D ≥ 1.5. Each sample
was tested using an Instron machine 4464 with a loading
cell of 1 kN under 10 repetitions. Two plates made of alu-
minum were used to compress the samples with a constant
velocity of 1 mmmin−1.
Outcomes of the test, namely, applied force (F) and
shortening (ΔL= L0−L), were acquired by a dedicated
software (LabVIEWTM, National Instruments) and statisti-
cally analyzed through Microsoft Excel (Windows Office
2010). To evaluate the compressive modulus (E), applied
Table 1 3DF scaffold
geometrical properties and
optimized processing parameters
Gauge (I.D.)
(µm)
Vdep
(mm/
min)
P (bar) T (°C) Designed Obtained Porosity (%)
d2 (µm) d3 (µm) d1 (µm) d2 (µm) d3 (µm)
G25 (250) 196 5 200 400 175 293 ± 27 410 ± 24 152 ± 65 28 ± 10
G27 (200) 56 5 200 400 150 200 ± 33 402 ± 33 150 ± 12 55 ± 5
The d1, d2, and d3 values were measured (n= 20) with ImageJ software on SEM images from the top-view
and cross section of the produced scaffolds. The obtained values for d1, d2, d3 and scaffold porosity are
reported as mean ± standard deviation (SD)
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force and shortening data were recorded to calculate both
stress (σ) and deformation (ε):
σ ¼ F
A0
; ð2Þ
ε ¼ ΔL
L0
; ð3Þ
where A0 and L0 are sample initial cross section and length,
respectively.
For each repetition, a study of the σ–ε curve was carried
out to determine the first linear part. Once identified, the
compressive modulus was calculated as the slope of the linear
region. A descriptive statistical analysis of the quantitative
data were presented as mean ± standard deviation (SD).
2.5 In vitro study
2.5.1 Ethical statement
HMSCs were obtained from bone marrow aspirates of patients
admitted to Pisa hospital for orthopedic surgery. Human
plasma was obtained by collecting leftovers from routinely
blood tests in our hospital. Samples were collected after
informed consent, treated anonymously and in conformity to
the principles expressed by the Declaration of Helsinki.
2.5.2 Isolation and culture of hMSCs
HMSC cultures were established as reported in our previous
studies [27]. Briefly, the aspirate was diluted 1:3 in sterile
saline and layered on Lymphoprep density gradient. After
centrifugation at 400×g for 25 min, the mononuclear cell
layer formed, which was taken out and suspended in culture
medium (CM), consisting of Alpha MEM, 2 mM L-gluta-
mine, 100 IU mL−1 penicillin, 100 mg mL−1 streptomycin
and 10% (v%) fetal bovine serum (FBS). The mononuclear
cells were suspended in CM were counted with a hemo-
cytometer using trypan blue to check their viability, and
finally cells at a density of 0.2 × 105 viable cells per cm2
were plated in tissue culture polystyrene flasks. After 24 h,
non-adherent cells were washed away from the cultures
using sterile saline and fresh CM was added to the adherent
cells. When the cultures reached about 70–80% confluence,
the adherent cells (i.e., the purified hMSCs) were detached
using 0.25% trypsin, replated at a cell density of 103 cells/
cm2 and expanded in regular CM until 70% confluence.
2.5.3 Culture and differentiation of hMSC/EAC wall scaffold
constructs
EAC wall scaffolds (n= 3) were sterilized with absolute
ethanol overnight and washed with PBS containing 3X pen-
strep and fungizone three times for 10 min. Due to the large
scaffold size, 12 × 106 cells were seeded in each sample to
obtain a complete cell colonization. To ensure a uniform
seeding, the following three strategies were performed
which availed themselves of multiple seeding shots (20 µL
each) with cells suspended either in gelatin (filtered 2%
aqueous solution) or in human pooled plasma, the latter
crosslinked using a 7 mM calcium chloride solution (0.4 µL
per µL of plasma) for 20 min [27]:
(1) hMSC/gelatin suspension: 4 × 106 cells (day 1)+ 6 ×
106 cells (day 6)+ 2 × 106 cells (day 12);
(2) hMSC/gelatin suspension: 4 × 106 cells (day 1)+ 8 ×
106 cells (day 9);
(3) hMSC/plasma suspension: 4 × 106 cells (day 1)+ 6 ×
106 cells (day 6)+ 2 × 106 cells (day 12).
Different seeding times were needed for a proper hMSC
expansion, thus reaching the necessary cell numbers. To
monitor cell localization in the scaffold, before reseeding
times, the alamarBlue® test was qualitatively performed
following the manufacturer’s recommendations and an
incubation time of 3 h. The slight pink-orange color retained
by the construct after CM removal allowed empty areas of
the scaffolds to be detected and thus seeded for an optimal
cell colonization. Stained constructs were photographed
with digital camera (Canon Digital Ixus 50). After com-
pletion of the seeding process, hMSC/scaffold constructs
were differentiated for further 21 days using osteogenic
CM, consisting of Alpha MEM supplemented with 10%
FBS, 2 mM L-glutamine, 100 U.I. mL−1 penicillin, 100 μg
mL−1 streptomycin, 1 μg mL−1 fungizone, with differ-
entiating factors 0.1 μM dexamethasone, 10 mM β-glycer-
ophosphate and 50 μg mL−1 ascorbic acid. Cell cultures
were carried out in incubator under standard conditions
(namely, 37 °C, 95% relative humidity, and 5% CO2/95%
air environment). At the endpoint, cell viability was quali-
tatively assessed by means of the Neutral Red assay.
Briefly, the constructs were incubated with 50 mgmL−1 of
the dye in CM for 3 h, rinsed in sterile PBS and observed
under an inverted light microscope (Nikon Ti-E, Nikon
Instruments, Tokyo, Japan). At the endpoint, the constructs
were fixed with formalin overnight and processed for SEM
and histologic analyses.
2.5.4 Biological characterization
After fixation and dehydration, the hMSC/scaffold con-
structs were sectioned with scissors. One piece per type was
sputter-coated with gold and observed under SEM to eval-
uate cell colonization and presence of ECM molecules. The
residual parts of the samples were processed for histo-
chemical analysis. Hematoxylin-eosin (H&E) staining was
used to analyze cell morphology and scaffold colonization
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following the standard anatomic-pathology protocol.
Mineral matrix deposition was evaluated by von Kossa
staining. For this analysis, the sections were incubated in
1% silver nitrate for 15 min in the light, in 0.5% pyrogallole
for 2 min and in 5% sodium thiosulfate for 2 min. Finally,
the specimens were counterstained in 0.1% nuclear fast red
Fig. 1 EAC prosthesis: a 3D
CAD model design by means of
SolidWorks software, b
polymeric bulk prototype, c, d
EAC scaffolds produced by
means of 3DF technique with
different nozzles: c gauge 25 (I.
D.= 250 µm), and d gauge 27
(I.D.= 200 µm)
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diluted in 5% aluminum sulfate solution for 5 min and
revealed in tap water for 5 min. The sections were observed
with a Nikon Eclipse Ci microscope (Nikon Instruments,
Amsterdam, The Netherlands) equipped with a digital
camera.
3 Results
3.1 Fabrication and characterization EAC wall
scaffolds
The production of the EAC wall scaffolds was performed
with the optimized parameters described in the previous
section. The overall dimensions of the CAD model were
10 × 20 × 20 mm3 (Fig. 1a). A solid 3D model was gener-
ated (Fig. 1a) which allowed a dimension comparison with
the bulk polymer counterpart produced by CNC micro-
milling (Fig. 1b). Owing to the complexity of the geometry
and the reduced thickness, some irregularities on the pre-
pared scaffolds were observed. The achieved accuracy, as
measured with a micrometer (Mitutoyo, Tokyo, Japan), was
less than 0.1 mm.
3DF deposition was therefore used to produce porous
EAC wall scaffolds using two different I.D. nozzles,
namely, G25 (I.D.= 250 µm) and G27 (I.D.= 200 µm).
The lack of structural support when the fibers were depos-
ited outside the limits of the previously built layers, some-
times hampered an accurate resolution; however,
satisfactory scaffolds were produced (Fig. 1c, d). The EAC
scaffold porosity was calculated according to the Equation
1, considering the volume of the scaffold obtained from the
3D CAD model. A gravimetric porosity of 28% ± 10% was
achieved with G25 nozzle. The values obtained for d1, d2
and d3 with the optimized processing parameters were 293
± 27, 410 ± 24 and 152 ± 65 µm, respectively (Table 1). The
compact texture of this scaffold was confirmed by SEM
observation (Fig. 2a, b). Indeed, the fibers were tightly
connected, especially on the scaffold outer surface, thus
resulting in low pore volume and poor pore inter-
connectivity. Due to the small scaffold thickness, an accu-
mulation of polymer on the pattern limits caused the fusion
of the layers observed in Fig. 2 A1. Moreover, no porosity
was observed on the external surface limiting the pore
interconnectivity (Fig. 2 A2). Furthermore, the obtained d3
was lower and with a large standard deviation when com-
pared to the designed value. This was probably attributed to
the low heat dissipation and slow polymer quenching while
the scaffold was being printed inducing a further compac-
tion of the scaffold in Z direction.
Improved pore interconnectivity and porosity was
achieved by using a nozzle with a smaller diameter (G27)
(Fig. 2b). In this case, a porosity of 55% ± 5% was
obtained. The values of d1, d2 and d3 were 200 ± 33 µm,
402 ± 33 µm and 150 ± 12 µm, respectively (Table 1).
However, the smaller the nozzle size, the higher the fab-
rication time of each EAC scaffold, which turned into a
significantly slow fabrication rate. After optimization with
a smaller nozzle diameter, completely open porosity was
obtained which could be observed both on scaffold cross-
section and external surfaces (Fig. 2 B1, B2). The EAC
wall scaffold produced using G27 was therefore chosen for
subsequent micro-CT, mechanical and biological
characterizations.
Fig. 2 SEM micrographs of
EAC wall scaffolds produced by
means of 3DF technique with a
G25 and b G27: (A1, B1) cross
sections and (A2, B2) outer
surfaces
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3D reconstructions of bulk and porous G27 EAC scaffolds
obtained via micro-CT analysis are shown in Fig. 3. Micro-
CT quantitative analysis showed a local thickness of the
fibers of 294 ± 130 µm (Tb.Th mean ± SD), with a volume
fraction occupied by the fibers of 60% (BV/TV) and a sur-
face/volume ratio of 9.52mm−1 (BS/BV) (Table 2). The
connectivity density was 21.2 mm−3 (Conn.D). Cross section
indeed showed highly interconnected pores (Fig. 3C3).
The mechanical characterization aimed at calculating the
Young’s modulus of the scaffold through compression tests
on samples with standardized dimensions (Fig. 4a). A
representative σ–ε curve of the compression test is shown in
Fig. 4b. The compressive Young’s modulus, calculated
from the linear region of the σ–ε curve was 25.1 ± 7.0 MPa.
Good deformation of the EAC shaped scaffolds is suppor-
tive for surgical handling during implantation (Supple-
mentary video S1).
3.2 Characterization of hMSC/EAC wall scaffold
constructs
AlamarBlue® as a non-disruptive assay was qualitatively
performed to visualize cell colonization before each
Fig. 3 Results of micro-CT
analysis: a 3D reconstruction, b
bulk EAC device, c porous EAC
scaffold (produced with gauge
G27). Pictures show both (A1,
B1, C1) convex, and (A2, B2,
C2) concave sides of the
scaffold. B3 and C3 are
representative cross sections of
bulk the device and the scaffold,
respectively
Table 2 Micro-CT parameters related to the EAC scaffold obtained
with gauge G27
Parameter Unit Bulk
device
EAC
scaffold
CAD
model
Mass mg 1080.4 694.8 —
Bulk volume mm3 947 764 898
Volume mm3 947 462 —
Volume/bulk volume — 1 0.605 —
Relative density (bulk) mg mm−3 1.141 0.909 —
Relative density mg mm−3 1.141 1.504 —
Surface mm2 1177 4398 1040
Surface/volume mm−1 1.243 9.519 1.158
External thickness (mean) mm 2.030 1.719 —
External thickness (SD) mm 0.129 0.232 —
External thickness (max) mm 2.110 1.991 —
Local thickness (mean) mm 2.030 0.294 —
Local thickness (SD) mm 0.129 0.130 —
Local thickness (max) mm 2.110 0.943 —
Connectivitya — 0 16173 0
Connectivity density mm−3 0 21.169 0
aConnectivity was defined as in [24]
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subsequent seeding step, aimed at obtaining homo-
geneously colonized scaffolds before osteoinduction. Due
to a metabolic reaction, alamarBlue® turns from blue to pink
in presence of live cells. Although the reaction affects the
CM, after CM removal, the pink color is still visible in 3D
cultures as some CM is locally retained by the scaffold
surrounding the metabolically active cells. As a repre-
sentative example, Fig. 5 shows hMSC colonization in an
EAC wall construct seeded according to the strategy “a”.
Constructs stained with alamarBlue® on day 6 and
12 showed some areas with low color intensity, which were
therefore addressed during the following seeding step (Fig.
5a, b). It can be observed that on day 12, color intensity
increased and color spatial distribution was improved with
respect to those on day 6, which is suggestive of enhanced
cell viability and distribution (Fig. 5a, b). In this way, all the
constructs seeded according to the three strategies appeared
homogeneously colonized before initiating osteogenic dif-
ferentiation. The presence of live cells at the endpoint was
assessed using Neutral Red assay, which showed scaffold
pores filled with viable and well stretched out cells
(Fig. 5c).
The surfaces of osteodifferentiated constructs were ana-
lyzed via SEM, which confirmed a good spatial coloniza-
tion of the EAC wall scaffolds seeded with the three
strategies (Fig. 6a-c). In all the samples, cells and ECM
molecules (Fig. 6a-c, lens) were observed. No significant
difference could be noticed among the constructs seeded
with three different strategies.
Finally, histological analysis was performed to investi-
gate in detail cell morphology, cell-scaffold interaction and
mineral matrix production. H&E staining highlighted cells
with round morphology typical of mature osteoblasts which
were both in tight contact with the scaffold fibers and filling
Fig. 4 Outcome of mechanical
test performed on EAC wall
scaffolds (G27) under
compressive mode: a test
samples with representative
dimensions and texture (lens),
and b the obtained stress-strain
curve, showing the linear part in
orange
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the inter-fiber porosity (Fig. 7a). Von Kossa staining
showed large production of mineral granules (in black), in
presence of cells (in red), which corroborated the hMSC
osteodifferentiation in all the samples, with no relevant
difference attributable to seeding strategies (Fig. 7b).
4 Discussion
This study focused on the fabrication and characterization
of EAC wall scaffolds via 3DF, as an additive manu-
facturing technique, to enable future devices for EAC
reconstruction under the TE paradigm, in which third gen-
eration biomaterials in the form of scaffolds interact with
the specific microenvironment and ultimately lead to the
functional restoration of the injured tissue.
The first generation biomaterials, also known as bioinert,
date back to the fifties and had the purpose to create of-the-
shelf devices with suitable physical properties to perma-
nently replace a tissue without any detrimental host
response. These biomaterials were conspicuously tested in
many body sites in the last century, and largely in the ear [6,
7]. The fate of bioinert biocompatible biomaterials is to
elicit a minimal inflammatory reaction and be ultimately
surrounded by a thin dense collagenous capsule [28].
However, a highly aggressive microenvironment caused by
chronic pathologies is present in the outer and middle ear,
which has always challenged any durable applications of
bioinert bulk devices for otologic applications [7]. In further
generation biomaterials, porosity has been considered as a
key feature at the device/tissue interface able to promote
tissue and vasculature ingrowth in place of a fibrotic
Fig. 5 Qualitative viability
staining showing cell
colonization on an EAC wall
scaffold seeded with the strategy
“a”, namely, hMSCs suspended
in gelatin and seeded in 3 steps:
a, b photographs of alamarBlue®
stained construct on day 6 (a)
and day 12 (b); c micrographs of
Neutral Red stained constructs at
the endpoint. Pictures show both
(A1, B1, C1) concave and (A2,
B2, C2) convex sides of the
scaffold
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capsule, which ultimately enabled the concept of porous
scaffolds for TE. The influence of porosity and pore size of
the EAC wall scaffolds is not largely documented in lit-
erature. It is a fact that examples of TE scaffolds for ear
applications are quite recent, if compared to other organs
[8–12]. Studies performed in the nineties by van Blitters-
wijk et al. [29] on porous hydroxylapatite ear implants,
including EAC wall prostheses, showed that the pores were
filled by new bone, firmly bonded to the hydroxyapatite
interface. Such implants were reported to have 31% por-
osity, distributed as 5% microporosity (pore diameter < 5
μm) and 26% macroporosity (pore diameter > 5 μm).
Macropores were filled with bone, fibrous tissue and
exudate, the latter due to ear infections. For scaffolds
designed for bone applications, the optimal pore size and
porosity are not consensual in literature, even if pores ran-
ging in 100–300 μm and above, but lower than 1000 μm, are
recommended to allow new bone ECM and capillary for-
mation [30]. It can be expected that highly porous scaffolds
provided with hundred micron-to-submillimeter pores will
allow fast regeneration and vascularization at the implan-
tation site, whereas both smaller and larger pores will favor
fibrous tissue infiltration. Due to the specific anatomy of the
ear, the accomplishment of high porosity and pore inter-
connectivity, as well as hundreds-micron pore size within
thin and curve shapes can be really challenging [9]. This
study showed that semicircular porous PEOT/PBT copoly-
mer scaffolds with 1.72 ± 0.23 mm overall thickness and
200 ± 33 µm diameter fibers could be fabricated via 3DF as
a manufacturing techniques. The best scaffold, obtained
using G27 needle, had averagely 55% gravimetric and
about 39.5% volumetric porosity, as the result of inter-
connected pores of ~200 µm (=d2–d1), the latter being in
line with the optimal pore size for bone regeneration.
Moreover, the produced scaffolds showed surface/volume
ratio 8 times higher than that of bulk device, which is
supportive of sufficient surface porosity for interacting with
the surrounding tissues. Even though the micro-CT mea-
surements showed fiber thickness and SD higher than those
obtained via SEM, it has to be noted that SEM and micro-
CT outcomes are independent measurements with different
precision and accuracy. In particular, the micro-CT based
local thickness measurements is based on the method of
Hildebrand et al. [22]. Briefly, this method aims to find the
largest sphere fully contained in the micro-CT segmented
structure at a given point to express the local thickness at
that point. Mean and SD of local thickness over the entire
structure are then reported. In this work, the reported
average micro-CT local fiber thickness can therefore
include the contribution of the contact points between the
fibers, where the maximal sphere is generally larger than
that passing through an isolated fiber.
A copolymer of PEOT/PBT family was first applied as
an eardrum replacement in a rat model in the nineties
showing interesting outcomes [31]. A salt-casted film with
100 μm thickness, 50% porosity and 160 μm pore size,
which induced a mild foreign body reaction after implan-
tation, followed by epithelialization, showed 50% biode-
gradation in one year timeframe. This biomaterial was
tested under Staphylococcus aureus-induced middle ear
infection, thus highlighting potential for otologic applica-
tions and corroborating the choice of PEOT/PBT copolymer
family for EAC wall manufacture, which should comply
with the several facets of biocompatibility, including suffi-
cient stability in an inflamed environment to allow new
tissue growth.
Fig. 6 SEM micrographs of osteoinduced hMSC/EAC wall scaffold
constructs, as obtained according to 3 different seeding strategies:
hMSCs suspended in gelatin and seeded in 3 steps (strategy “a”) (a);
hMSCs suspended in gelatin and seeded in 2 steps (strategy “b”) (b);
hMSCs suspended in plasma and seeded in 3 steps (strategy “c”) (c).
Lens show cellular details at ×500 magnification
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As a non-load bearing bone, EAC wall prosthesis has a
reduced demand in terms of necessary mechanical proper-
ties. However, since porosity can remarkably affect the
mechanical behavior of materials, in this study the com-
pressive modulus of cylindrical samples fabricated with the
same pattern and needle of EAC wall scaffolds was eval-
uated to ensure compliance of the device structural integrity
with the implantation procedure. The obtained compressive
modulus, 25.1 ± 7.0 MPa, is of the order of magnitude
reported for stiff cartilage [32]. As such, the produced
scaffolds can be considered mechanically similar but still
less stiff than the native EAC wall, which is osseo-cartilage.
A mechanical compatibility with the surrounding tissues is
also desirable for an improved biocompatibility [28]. The
chosen fabrication strategy, including copolymer and pro-
duction parameters, allowed the accomplishment of archi-
tectural and mechanical features theoretically suitable for
this application. However, the stiffness of the polymeric
scaffold may be further enhanced by incorporating hydro-
xyapatite nano-particles in order to match the stiffness of
trabecular bone [33].
Therefore, in vitro experiments were carried out to
investigate preliminary biological interactions of the EAC
wall scaffold with hMSCs under osteogenic commitment.
Indeed, it is expected that resident cells will repopulate the
scaffolds and produce ECM, to reach the final composi-
tional and mechanical characteristics of EAC wall. In par-
ticular, the inner two thirds of EAC has very thin epidermis,
lacks of ceruminous glands and is made of bone, not car-
tilage. Therefore, bone regeneration appears the most
important event for this application. In fact, in vivo studies
using porous implants for EAC wall reconstruction reported
the infiltration of bony tissue [29]. Owing to the large
volume and surface area, cell seeding was performed on real
size EAC wall scaffolds using multiple steps, namely, either
two or three seeding steps, each one consisting of several
Fig. 7 Micrographs showing the
histological outcomes,
specifically: a H&E staining and
b von Kossa staining of
osteoinduced hMSC/EAC wall
scaffold constructs, as obtained
according to three different
seeding strategies: (1) hMSCs
suspended in gelatin and seeded
in 3 steps (strategy “a”); (2)
hMSCs suspended in gelatin and
seeded in 2 steps (strategy “b”);
(3) hMSCs suspended in plasma
and seeded in 3 steps (strategy
“c”)
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shots distributed along the body of the scaffold, which
ultimately led to twelve million hMSCs seeded in each
sample. Three seeding strategies were tested, including cells
suspended in a gelatin aqueous solution with two different
time schedules, or in pooled plasma, the latter transformed
right after into a clot by crosslinking with calcium chloride
to minimize cell loss [27]. Using a viable dye in between
each seeding time-point permitted the empty areas to be
localized, to which the second and third seeding shots were
applied. In the end, all the scaffolds resulted uniformly
colonized and vital hMSCs could be observed inside the
pores. Under osteogenic commitment for 21 days, the cells
remained viable and were able to produce a thick layer of
mineral matrix with nodular appearance, as revealed by
SEM and von Kossa staining, without appreciable differ-
ences among the diversely seeded samples. This biological
study showed preliminary evidence supporting the use of
3DF scaffolds for EAC wall reconstruction and will hope-
fully pave the way for novel effective otologic devices and
procedures using TE substitutes.
5 Conclusions
This study demonstrated the fabrication feasibility of EAC
wall scaffolds aimed to match several important require-
ments for biomaterial application to the ear under the TE
paradigm, including shape, porosity and pore size, surface
area, mechanical properties and favorable in vitro interac-
tion with osteo-differentiated hMSCs. Fiber size and scaf-
fold porosity were optimized, leading to 200 ± 33 µm and
55% ± 5%, respectively. The compressive modulus was
25.1 ± 7.0 MPa, which is lower than that of the EAC as an
osseocartilaginous tissue, but still in the order of stiff car-
tilage. HMSCs uniformly colonized the scaffolds and pro-
duced mineral matrix within the fibers. The possibility of
producing curve porous thin and sufficiently strong struc-
tures with high accuracy of external geometry and internal
pore architecture by means of 3DF techniques may allow in
the future the production of customized ear implants of
improved biocompatibility and functionality.
Acknowledgements The Italian Ministry of University and Research
(MIUR, PRIN 2010S58B38) and the Tuscany Region (Health Program
2009 and CUCCS 2014) are greatly acknowledged for funding this
research. S.D. and D.P. would like to thank the ARPA Foundation
young researchers’ award, Decree #21, 20 December 2011, Medicine
Faculty, University of Pisa. This research project received support
from the Dutch Province of Limburg. Dr. Delfo D’Alessandro (Uni-
versity of Pisa) is kindly acknowledged for his remarkable technical
support to histologic analysis.
Author contributions C.M., L.B., and S.D. designed the experiments.
C.M., M.M., D.P., L.T., and S.D. performed the experiments. C.M.,
M.M., D.P., and L.T. analyzed the data. C.M., V.G., and S.D. drafted
the manuscript. P.A.S., S.G., C.S., L.M., and S.B. provided reagents
and tools.
Compliance with ethical standards
Conflict of interest The authors declare that they have no conflict of
interest.
References
1. Fatterpekar GM, Doshi AH, Dugar M, Delman BN, Naidich TP,
Som PM. Role of 3D CT in the Evaluation of the Temporal Bone.
Radiogrphics. 2006;26(S1):17–32. https://doi.org/10.1148/rg.
26si065502
2. Chatra P. Lesions in the external auditory canal. Indian J Radiol
Imaging. 2011;21(4):274. https://doi.org/10.4103/0971-3026.
90687
3. Dankuc D, Vlaski L, Pejakovic N. Techniques of the tympano-
mastoidectomy with reconstruction of the posterior bone wall of
the external auditory canal. Srp Arh Celok Lek. 2015;143
(7–8):480–6. https://doi.org/10.2298/SARH1508480D
4. Heywood R, Narula A. The pros and cons of canal wall up versus
canal wall down mastoidectomy for cholesteatoma. Otorhinolar-
yngologist. 2013;6(3):140–3.
5. Wullstein SR, Schindler K, Döll W. Further observations on
application of “plasticin” in ear surgery. In: Grote JJ, editor.
Biomaterials in otology. Leiden: Springer Netherlands; 1984. p.
250–61. https://doi.org/10.1007/978-94-009-6756-4_30
6. Dormer KJ, Gan RZ. Biomaterials for implantable middle ear
hearing devices. Otolaryngol Clin North Am. 2001;34:289–97.
7. Beutner D, Hüttenbrink KB. Passive and active middle ear
implants. GMS Curr Top Otorhinolaryngol Head Neck Surg.
2009;8:Doc09.
8. Danti S, Stefanini C, D’Alessandro D, Moscato S, Pietrabissa A,
Petrini M, et al. Novel biological/biohybrid prostheses for the
ossicular chain: fabrication feasibility and preliminary functional
characterization. Biomed Micro. 2009;11(4):783–93. https://doi.
org/10.1007/s10544-009-9293-9
9. Danti S, D’Alessandro D, Pietrabissa A, Petrini M, Berrettini S.
Development of tissue-engineered substitutes of the ear ossicles:
PORP-shaped poly(propylene fumarate)-based scaffolds cultured
with human mesenchymal stromal cells. J Biomed Mater Res A.
2010;92(4):1343–56. https://doi.org/10.1002/jbm.a.32447
10. Mota C, Danti S, D’Alessandro D, Trombi L, Ricci C, Puppi D,
et al. Multiscale fabrication of biomimetic scaffolds for tympanic
membrane tissue engineering. Biofabrication. 2015;7(2):025005
https://doi.org/10.1088/1758-5090/7/2/025005
11. Danti S, Mota C, D’alessandro D, Trombi L, Ricci C, Redmond
SL, et al. Tissue engineering of the tympanic membrane using
electrospun PEOT/PBT copolymer scaffolds: a morphological
in vitro study. Hear, Balance Commun. 2015;13(4):133–47.
https://doi.org/10.3109/21695717.2015.1092372
12. Zein I, Hutmacher DW, Tan KC, Teoh SH. Fused deposition
modeling of novel scaffold architectures for tissue engineering
applications. Biomaterials. 2002;23(4):1169–85. https://doi.org/
10.1016/S0142-9612(01)00232-0
13. Moroni L, Poort G, Van Keulen F, de Wijn JR, van Blitterswijk
CA. Dynamic mechanical properties of 3D fiber-deposited PEOT/
PBT scaffolds: an experimental and numerical analysis. J Biomed
Mater Res A. 2006;78(3):605–14. https://doi.org/10.1002/jbm.a.
30716
14. Moroni L, de Wijn JR, van Blitterswijk CA. Three-dimensional
fiber-deposited PEOT/PBT copolymer scaffolds for tissue engi-
neering: influence of porosity, molecular network mesh size, and
Journal of Materials Science: Materials in Medicine (2018) 29:63 Page 13 of 14 63
swelling in aqueous media on dynamic mechanical properties. J
Biomed Mater Res A. 2005;75(4):957–65. https://doi.org/10.
1002/jbm.a.30499
15. Moroni L, de Wijn JR, van Blitterswijk CA. 3D fiber-deposited
scaffolds for tissue engineering: influence of pores geometry and
architecture on dynamic mechanical properties. Biomaterials.
2006;27(7):974–85. https://doi.org/10.1016/j.biomaterials.2005.
07.023
16. Moroni L, Curti M, Welti M, Korom S, Weder W, de Wijn JR,
et al. Anatomical 3D fiber-deposited scaffolds for tissue engi-
neering: designing a neotrachea. Tissue Eng. 2007;13
(10):2483–93. https://doi.org/10.1089/ten.2006.0385
17. Moroni L, Schotel R, Hamann D, de Wijn JR, van Blitterswijk
CA. 3D fiber-deposited electrospun integrated scaffolds enhance
cartilage tissue formation. Adv Funct Mater. 2008;18(1):53–60.
https://doi.org/10.1002/adfm.200601158
18. Agarwal S, Wendorff JH, Greiner A. Progress in the field of elec-
trospinning for tissue engineering applications. Adv Mater. 2009;21
(32-33):3343–51. https://doi.org/10.1002/adma.200803092
19. Moroni L, de Wijn JR, van Blitterswijk CA. Integrating novel
technologies to fabricate smart scaffolds. J Biomater Sci Polym Ed.
2008;19(5):543–72. https://doi.org/10.1163/156856208784089571
20. Woodfield TB, Miot S, Martin I, van Blitterswijk CA, Riesle J.
The regulation of expanded human nasal chondrocyte re-
differentiation capacity by substrate composition and gas plasma
surface modification. Biomaterials. 2006;27(7):1043–53. https://
doi.org/10.1016/j.biomaterials.2005.07.032
21. Odgaard A. Three-dimensional methods for quantification of
cancellous bone architecture. Bone. 1997;20(4):315–28.
22. Hildebrand T, Ruegsegger P. A new method for the model-
independent assessment of the thickness in three-dimensional
images. J Microsc. 1997;185(1):67–75.
23. Panetta D, Belcari N, Del Guerra A, Bartolomei A, Salvadori PA.
Analysis of image sharpness reproducibility on a novel engineered
micro-CT scanner with variable geometry and embedded recali-
bration software. Phys Med. 2012;28(2):166–73. https://doi.org/
10.1016/j.ejmp.2011.03.006
24. Doube M, Kłosowski MM, Arganda-Carreras I, Cordelières FP,
Dougherty RP, Jackson JS, Schmid B, Hutchinson JR, Shefelbine
SJ. BoneJ: Free and extensible bone image analysis in Image. J
Bone. 2010;47(6):1076–9. https://doi.org/10.1016/j.bone.2010.08.
023
25. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ:
25 years of image analysis. Nat Methods. 2012;9(7):671–5.
https://doi.org/10.1038/nmeth.2089
26. Jerabek M, Major Z, Lang RW. Uniaxial compression testing of
polymeric materials. Polym Test. 2010;29:302–9.
27. Trombi L, Danti S, Savelli S, Moscato S, D’Alessandro D, Ricci
C, et al. Mesenchymal stromal cell culture and delivery in auto-
logous conditions: a smart approach for orthopedic applications. J
Vis Exp. 2016. https://doi.org/10.3791/54845
28. Williams DF. On the mechanisms of biocompatibility. Bioma-
terials. 2008;29:2941–53.
29. Van Blitterswijk CA, Hesseling SC, Grote JJ, Koerten HK, de
Groot K. The biocompatibility of hydroxyapatite ceramic: a study
of retrieved human middle ear implants. J Biomed Mater Res.
1990;24(4):433–53. https://doi.org/10.1002/jbm.820240403
30. Karageorgiou V, Kaplan D. Porosity of 3D biomaterial scaffolds
and osteogenesis. Biomaterials. 2005;26(27):5474–91. https://doi.
org/10.1016/j.biomaterials.2005.02.002
31. Bakker D, van Blitterswijk CA, Hesseling SC, Th. Daems W,
Kuijpers W, Grote JJ. The behavior of alloplastic tympanic
membranes in Staphylococcus aureus-induced middle ear infec-
tion. I. Quantitative biocompatibility evaluation. J Biomed Mater
Res. 1990;24(6):669–88. https://doi.org/10.1002/jbm.820240604
32. Barker MK, Seedhom BB. The relationship of the compressive
modulus of articular cartilage with its deformation response to
cyclic loading: does cartilage optimize its modulus so as to
minimize the strains arising in it due to the prevalent loading
regime? Rheumatology. 2001;40(3):274–84. https://doi.org/10.
1093/rheumatology/40.3.274
33. De Santis R, D’Amora U, Russo T, Ronca A, Gloria A, Ambrosio
L. 3D fibre deposition and stereolithography techniques for the
design of multifunctional nanocomposite magnetic scaffolds. J
Mater Sci. 2015. https://doi.org/10.1007/s10856-015-5582-4.
63 Page 14 of 14 Journal of Materials Science: Materials in Medicine (2018) 29:63
